The effect of a single 4CMenB vaccine booster in young people more than ten years after infant immunisation: protocol of an exploratory immunogenicity study

<p><strong>Background and rationale</strong></p> <p>The four-component capsular group B meningococcal vaccine (4CMenB) was introduced into the national immunisation schedule in the UK in September 2015 for infants in a 2 + 1 schedule at two, four and 12 months of age. A...

詳細記述

書誌詳細
主要な著者: Davis, K, Ford, K, Craik, R, Galal, U, Rollier, C, Pollard, A
フォーマット: Journal article
言語:English
出版事項: BioMed Central 2019